GH1 and chronic kidney disease: Given the strong phenotypic similarity between α-Klotho knockout models and CKD, and the wide range of CKD-related pathologies that in experimental studies can be attenuated by exogenous α-Klotho, additional exploration is warranted of all options that upregulate endogenous α-Klotho, including GH therapy.